Related content

Implementation of CYP2D6 genotyping in psychiatry

By Loovers Harriët M   van der Weide Jan  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 9, 2009-09 ,pp. : 1065-1077

Informa Healthcare

Access to resources Recommend Favorite

Genetic Polymorphism in Cytochrome P450 2D6 (CYP2D6): Population Distribution of CYP2D6 Activity

By Neafsey Patricia  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 334-361

Taylor & Francis Ltd

Access to resources Recommend Favorite

CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene

By Skierka Jennifer M   Walker Denise L   Peterson Sandra E   O’Kane Dennis J   Black John Logan  

Pharmacogenomics, Vol. 13, Iss. 8, 2012-06 ,pp. : 951-954

Future Medicine

Access to resources Recommend Favorite

CYP2D6 metabolism determines drug use in psychiatric disorders

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 419, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Pharmacogenetic Screening of the Gene Deletion and Duplications of CYP2D6

By Meijerman Irma   Sanderson Linda   Smits Paul   Beijnen Jos   Schellens Jan  

Drug Metabolism Reviews, Vol. 39, Iss. 1, 2007-01 ,pp. : 45-60

Informa Healthcare

Access to resources Recommend Favorite